Active, Not Recruiting
A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer
NCT04315701
- Conditions
- Neoplasms, Neoplasms by Site, Recurrent Skin Squamous Cell Carcinoma, +7 more
- Locations
-
- Los Angeles County-USC Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Hoag Memorial Hospital Newport Beach, California, United States
- Northwestern University Feinberg School of Medicine Chicago, Illinois, United States